N/A
N=14,144
COVID-19 Health Messaging to Underserved Communities
Coronavirus
Bottom Line
View on ClinicalTrials.gov: NCT04371419 ↗Enrolled (actual)
14,144
Serious AEs
0.0%
Results posted
Jul 2021
Primary outcome: Primary: Incidence Rate for Knowledge Gaps: Control vs. Any Intervention — 0.085; 0.065 proportion of knowledge gaps
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Messaging (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- National Bureau of Economic Research, Inc.
- Primary completion
- May 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Incidence Rate for Knowledge Gaps: Control vs. Any Intervention |
0.085; 0.065 | — |
| PRIMARY Incidence Rate for Information-seeking Behavior: Control vs. Any Intervention |
0.335; 0.344 | — |
| PRIMARY Incidence Rate for Knowledge Gaps by Intervention |
0.066; 0.065; 0.065; 0.068; 0.066; 0.063 | — |
| PRIMARY Incidence Rate for Information-seeking Behavior by Intervention |
0.336; 0.353; 0.343; 0.348; 0.346; 0.341 | — |
Summary
Recent data have shown that covid19 is disproportionately infecting and killing African Americans and Latinx people in the United States. The aim of the study is to determine which messages are most effective at increasing knowledge and changing behaviors that can protect individuals and their communities from the virus. To accomplish this aim, we plan to recruit approximately 20,000 Hispanic and African-American individuals and randomly assign them to videos that vary either the sender or the framing of the message, while providing the relevant public health information.
Eligibility Criteria
Inclusion Criteria: Hispanic and African-American adult individuals, men and women - oversample of those with less completed education Exclusion Criteria: children, those who do not identify as above
Data sourced from ClinicalTrials.gov (NCT04371419). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.